Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Negative Control in Microbiological Testing

Posted on By

Standard Operating Procedure for Negative Control

Purpose

The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for maintaining negative control samples to ensure the validity of test results in the pharmaceutical manufacturing facility.

Scope

This SOP applies to all personnel involved in the maintenance and use of negative control samples within the pharmaceutical manufacturing facility.

Responsibilities

  • Quality Control (QC) Department: Responsible for overseeing the implementation and compliance of this SOP.
  • Microbiologist: Responsible for maintaining negative control samples and ensuring proper documentation.
  • Production Personnel: Responsible for using negative control samples during testing procedures.
See also  SOP for Microbiological Method Validation

Procedure

  1. Selection of Negative Controls:
    • Identify suitable negative control organisms or samples that are free from the target microorganisms being tested for.
    • Verify the purity and absence of microbial contamination in negative control samples prior to use.
  2. Storage and Handling:
    • Store negative control samples separately from test samples to prevent cross-contamination.
    • Ensure proper labeling and identification of negative control samples to avoid mix-ups during testing procedures.
    • Handle negative control samples using aseptic techniques to maintain their integrity and prevent contamination.
  3. Documentation:
    • Maintain detailed records of negative control samples including their source, preparation, storage conditions, and expiration dates.
    • Document any deviations or incidents related to negative control samples and take appropriate corrective actions as necessary.
  4. Verification of Test Results:
    • Incorporate negative control samples into testing procedures to
verify the absence of false-positive results.
  • Include negative control samples in each batch of tests to ensure the validity and accuracy of test results.
  • Periodic Review:
    • Regularly review and update the list of negative control samples based on evolving testing requirements and regulatory standards.
    • Perform periodic checks to ensure the continued purity and integrity of negative control samples over time.
  • Abbreviations

    • SOP: Standard Operating Procedure
    • QC: Quality Control

    Documents

    • Negative Control Sample Inventory
    • Incident Reports
    • Verification Records

    Reference

    United States Pharmacopoeia (USP) General Chapter Microbiological Attributes of Non-sterile Pharmaceutical Products

    SOP Version

    Version 1.0

    See also  Sop for Maintaining Positive Control Organisms
    Microbiology Testing Tags:Bioburden testing, Change control management, Data review processes, Decontamination techniques, Disinfection procedures, Endotoxin testing, Environmental data trending, Environmental monitoring, Equipment Calibration, Excipient control, GMP compliance, Incident investigation, Incubation conditions, Laboratory safety guidelines, Media fill testing, Media preparation, Method Validation, Microbial contamination control, Microbial strain verification, Quality control measures, Raw Material Testing, Reagent preparation, Sampling protocols, Sterility testing, Water quality testing

    Post navigation

    Previous Post: SOP for Microbial Limit Testing
    Next Post: Microbiology Testing: SOP for Endotoxin Testing

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version